Martina Gobec

Ljubljana, 1000, Slovenia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

α-Aminoboronic Acid Moieties in Boro Dipeptides Modulate Proteasome Subunit Selectivity and Provide Access to Compounds with Potent Anticancer and Anti-Inflammatory Activity.

α-Aminoboronic Acid Moieties in Boro Dipeptides Modulate Proteasome Subunit Selectivity and Provide Access to Compounds with Potent Anticancer and Anti-Inflammatory Activity.

Journal: Journal of medicinal chemistry

Published: December 04, 2025

Enhancing Solubility in VHL-Based PROTACs: Optimized USP7 Degraders for Improved Developability.

Enhancing Solubility in VHL-Based PROTACs: Optimized USP7 Degraders for Improved Developability.

Journal: Journal of medicinal chemistry

Published: July 17, 2025

OSMI-4-based PROTACs do not influence O-GlcNAc transferase and O-GlcNAcylation levels in cells.

OSMI-4-based PROTACs do not influence O-GlcNAc transferase and O-GlcNAcylation levels in cells.

Journal: RSC advances

Published: April 22, 2025

Adaptive immune cell reactivity to polycaprolactone, alginate, chitosan, and zein nanofibers.

Adaptive immune cell reactivity to polycaprolactone, alginate, chitosan, and zein nanofibers.

Journal: International journal of biological macromolecules

Published: April 04, 2025

Catalytic proteasome subunits are heterogeneously active in human platelets with β1i playing a role in signaling and granule release.

Catalytic proteasome subunits are heterogeneously active in human platelets with β1i playing a role in signaling and granule release.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: January 07, 2025

Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L.

Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L.

Journal: Seminars in thrombosis and hemostasis

Published: October 08, 2024

New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer.

New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer.

Journal: Journal of medicinal chemistry

Published: July 23, 2024

Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists.

Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists.

Journal: Journal of medicinal chemistry

Published: February 01, 2024

Design, Synthesis, and Evaluation of BCL-2 Targeting PROTACs.

Design, Synthesis, and Evaluation of BCL-2 Targeting PROTACs.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: January 31, 2024

A systematic review and meta-analysis of carfilzomib-associated thrombocytopenia as an adverse event in patients with multiple myeloma.

A systematic review and meta-analysis of carfilzomib-associated thrombocytopenia as an adverse event in patients with multiple myeloma.

Journal: Therapeutic advances in hematology

Published: December 11, 2023

Halogenation of common phenolic household and personal care product ingredients enhances their AhR-modulating capacity.

Halogenation of common phenolic household and personal care product ingredients enhances their AhR-modulating capacity.

Journal: Chemosphere

Published: October 04, 2023

Design and synthesis of amino-substituted N-arylpiperidinyl-based inhibitors of the (immuno)proteasome.

Design and synthesis of amino-substituted N-arylpiperidinyl-based inhibitors of the (immuno)proteasome.

Journal: Acta pharmaceutica (Zagreb, Croatia)

Published: July 02, 2023

Showing 1-12 of 56

Last Updated: 09/26/2026